Prostate cancer
Conditions
Interventions
None listed
Sponsors
Department of Urology, Kindai University Nara Hospital.
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: Prostate cancer group 1.Patients who received androgen deprivation therapy. 2.Eastern Cooperative Oncology Group performance status (ECOG-PS): 0-2. 3.Expected survival is more than 12 months. 4.Patients who understand this research plan and have given their consent. Control group 1.Patients with suspected prostate cancer who require regular monitoring. 2.Eastern Cooperative Oncology Group performance status (ECOG-PS): 0-2. 3.Expected survival is more than 12 months. 4.Patients who understand this research plan and have given their consent.
Exclusion criteria
Exclusion criteria: 1.Patients with active other malignancy. 2.Patients with or confirmed a history of cognitive impairment. 3.Patients with other serious disease or condition. 4.Patients deemed inappropriate by the attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of the change in cognitive function between patients with prostate cancer treated with androgen deprivation therapy and control group. | — |
Secondary
| Measure | Time frame |
|---|---|
| Relationship between the change in cognitive function and patients' characteristics. | — |
Countries
Japan
Contacts
Public ContactYutaka Yamamoto
Kindai University Nara Hospital Department of Urology
Outcome results
None listed